NPI: 1073060257 · SYRACUSE, NY 13202 · Clinical Medical Laboratory · NPI assigned 09/06/2016
Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | WILLIAMS, KIMBERLY (VICE PRESIDENT) |
| NPI Enumeration Date | 09/06/2016 |
Other providers sharing the same authorized official: WILLIAMS, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,909 | $302K |
| 2019 | 16,755 | $319K |
| 2020 | 19,912 | $430K |
| 2021 | 24,124 | $597K |
| 2022 | 24,806 | $635K |
| 2023 | 26,853 | $576K |
| 2024 | 18,989 | $409K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 46,657 | 46,529 | $916K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 30,890 | 30,779 | $658K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 11,964 | 11,581 | $497K |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 3,293 | 3,287 | $312K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 13,191 | 13,148 | $229K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 13,109 | 13,067 | $228K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 4,879 | 4,860 | $87K |
| 88141 | 10,715 | 10,684 | $84K | |
| 88307 | 1,074 | 942 | $67K | |
| 88142 | 3,794 | 3,786 | $58K | |
| 87625 | 2,970 | 2,946 | $52K | |
| 88342 | 1,156 | 1,125 | $34K | |
| 88341 | 402 | 392 | $18K | |
| 88304 | 838 | 809 | $14K | |
| 88300 | 738 | 691 | $5K | |
| 81422 | 171 | 169 | $3K | |
| 88112 | 66 | 66 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 51 | 50 | $2K |
| 88302 | 127 | 124 | $1K | |
| 81479 | Unlisted molecular pathology procedure | 171 | 169 | $564.30 |
| 88360 | 12 | 12 | $412.99 | |
| 87660 | 29 | 29 | $288.10 | |
| 88312 | 13 | 13 | $190.49 | |
| 87510 | 13 | 13 | $139.78 | |
| 87480 | 13 | 13 | $139.78 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 12 | 12 | $126.00 |